See more : Pharma-Bio Serv, Inc. (PBSV) Income Statement Analysis – Financial Results
Complete financial analysis of Core Molding Technologies, Inc. (CMT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Molding Technologies, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Sientra, Inc. (SIEN) Income Statement Analysis – Financial Results
- Business First Bancshares, Inc. (BFST) Income Statement Analysis – Financial Results
- Green Stream Holdings Inc. (GSFI) Income Statement Analysis – Financial Results
- Vinco Ventures, Inc. (BBIG) Income Statement Analysis – Financial Results
- Aspocomp Group Oyj (ACG1V.HE) Income Statement Analysis – Financial Results
Core Molding Technologies, Inc. (CMT)
About Core Molding Technologies, Inc.
Core Molding Technologies, Inc., together with its subsidiaries, operates as a molder of thermoplastic and thermoset structural products. The company offers a range of manufacturing processes that include compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics, and structural foam and structural web injection molding. It serves various markets, including medium and heavy-duty truck, automobile, power sport, construction, agriculture, building products, and other commercial markets in the United States, Mexico, Canada, and internationally. The company was formerly known as Core Materials Corporation and changed its name to Core Molding Technologies, Inc. in August 2002. Core Molding Technologies, Inc. was incorporated in 1996 and is headquartered in Columbus, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 357.74M | 377.38M | 307.48M | 222.36M | 284.29M | 269.49M | 161.67M | 174.88M | 199.07M | 175.20M | 144.13M | 162.45M | 143.42M | 100.26M | 83.34M | 116.65M | 122.71M | 162.33M | 130.54M | 111.85M | 92.78M | 94.09M | 68.37M | 83.55M | 90.60M | 77.70M | 64.90M |
| Cost of Revenue | 293.22M | 324.97M | 266.14M | 187.88M | 262.78M | 242.34M | 136.99M | 146.96M | 162.82M | 145.02M | 120.55M | 136.60M | 113.54M | 83.91M | 71.91M | 95.45M | 105.74M | 132.46M | 107.06M | 94.54M | 78.89M | 80.27M | 60.53M | 69.96M | 78.29M | 60.70M | 48.80M |
| Gross Profit | 64.52M | 52.40M | 41.34M | 34.47M | 21.51M | 27.14M | 24.68M | 27.92M | 36.25M | 30.19M | 23.57M | 25.85M | 29.88M | 16.35M | 11.43M | 21.21M | 16.97M | 29.87M | 23.48M | 17.31M | 13.90M | 13.82M | 7.83M | 13.58M | 12.31M | 17.00M | 16.10M |
| Gross Profit Ratio | 18.04% | 13.89% | 13.45% | 15.50% | 7.56% | 10.07% | 15.27% | 15.97% | 18.21% | 17.23% | 16.36% | 15.91% | 20.84% | 16.31% | 13.71% | 18.18% | 13.83% | 18.40% | 17.99% | 15.48% | 14.98% | 14.69% | 11.46% | 16.26% | 13.59% | 21.88% | 24.81% |
| Research & Development | 1.70M | 1.60M | 1.30M | 1.17M | 1.17M | 1.03M | 848.00K | 965.00K | 719.00K | 475.00K | 466.00K | 449.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 37.76M | 34.28M | 30.11M | 24.08M | 28.93M | 27.84M | 16.69M | 16.38M | 17.75M | 15.54M | 13.46M | 13.36M | 12.94M | 9.93M | 8.94M | 12.02M | 11.40M | 14.01M | 13.09M | 10.74M | 9.49M | 9.24M | 7.94M | 9.05M | 9.14M | 7.80M | 7.50M |
| Selling & Marketing | 0.00 | 124.00K | 162.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 37.76M | 34.40M | 30.28M | 24.08M | 28.93M | 27.84M | 16.69M | 16.38M | 17.75M | 15.54M | 13.46M | 13.36M | 12.94M | 9.93M | 8.94M | 12.02M | 11.40M | 14.01M | 13.09M | 10.74M | 9.49M | 9.24M | 7.94M | 9.05M | 9.14M | 7.80M | 7.50M |
| Other Expenses | -1.48M | 124.00K | 162.00K | 80.00K | 94.00K | 48.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.67M | 1.45M | 1.50M | 2.00M |
| Operating Expenses | 37.98M | 34.40M | 30.28M | 24.08M | 28.93M | 27.84M | 16.69M | 16.38M | 17.75M | 15.54M | 13.46M | 13.36M | 12.94M | 9.93M | 8.94M | 12.02M | 11.40M | 14.01M | 13.09M | 10.74M | 9.49M | 9.24M | 7.94M | 10.72M | 10.59M | 9.30M | 9.50M |
| Cost & Expenses | 331.20M | 359.37M | 296.42M | 211.97M | 291.72M | 270.18M | 153.68M | 163.34M | 180.57M | 160.56M | 134.01M | 149.96M | 126.48M | 93.84M | 80.85M | 107.47M | 117.14M | 146.47M | 120.15M | 105.27M | 88.38M | 89.51M | 68.47M | 80.68M | 88.88M | 70.00M | 58.30M |
| Interest Income | 0.00 | 1.96M | 2.31M | 5.34M | 4.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 542.17K | 645.12K | 226.20K | 6.58K | 87.51K | 132.92K | 305.00K | 339.51K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.01M | 1.96M | 2.31M | 5.92M | 4.14M | 2.39M | 245.00K | 298.00K | 330.00K | 122.00K | 214.00K | 334.00K | 696.00K | 1.34M | 951.05K | 689.14K | 717.16K | 488.31K | 750.76K | 872.30K | 1.85M | 2.03M | 2.00M | 1.97M | 0.00 | 1.70M | 0.00 |
| Depreciation & Amortization | 12.83M | 11.88M | 11.62M | 11.66M | 10.38M | 9.38M | 6.24M | 6.28M | 6.04M | 5.02M | 4.88M | 4.52M | 3.94M | 3.95M | 3.86M | 3.54M | 3.41M | 2.07M | 1.80M | 1.65M | 1.71M | 1.64M | 1.60M | 1.67M | 1.45M | 1.50M | 2.00M |
| EBITDA | 39.67M | 30.41M | 22.85M | 20.93M | -1.13M | 6.17M | 14.80M | 17.74M | 24.54M | 19.67M | 14.99M | 17.02M | 20.89M | 10.37M | 6.34M | 12.73M | 9.52M | 17.92M | 12.20M | 8.22M | 6.11M | 6.22M | 1.48M | 4.53M | 3.17M | 9.20M | 8.64M |
| EBITDA Ratio | 11.09% | 7.95% | 7.43% | 9.95% | -2.58% | -0.24% | 4.94% | 6.60% | 9.29% | 8.36% | 7.17% | 10.47% | 14.56% | 10.34% | 7.61% | 10.92% | 7.32% | 11.04% | 9.34% | 7.35% | 6.59% | 6.08% | 2.18% | 5.42% | 3.49% | 11.45% | 12.94% |
| Operating Income | 26.54M | 18.00M | 11.07M | 10.39M | -7.43M | -3.10M | 7.99M | 11.55M | 18.50M | 14.65M | 10.11M | 12.49M | 16.94M | 6.42M | 2.49M | 9.19M | 5.57M | 15.86M | 10.39M | 6.57M | 4.40M | 4.58M | -108.00K | 2.86M | 1.72M | 7.70M | 6.60M |
| Operating Income Ratio | 7.42% | 4.77% | 3.60% | 4.67% | -2.61% | -1.15% | 4.94% | 6.60% | 9.29% | 8.36% | 7.02% | 7.69% | 11.81% | 6.40% | 2.98% | 7.88% | 4.54% | 9.77% | 7.96% | 5.88% | 4.75% | 4.87% | -0.16% | 3.43% | 1.90% | 9.91% | 10.17% |
| Total Other Income/Expenses | -791.00K | -3.42M | -2.15M | -5.84M | -4.05M | -2.35M | -196.00K | -280.00K | -330.00K | -122.00K | -241.00K | -338.00K | -696.00K | -1.34M | -951.05K | -689.14K | -175.00K | 156.81K | -524.56K | -865.71K | -1.76M | -1.39M | -1.69M | -1.63M | -1.59M | -1.40M | -2.04M |
| Income Before Tax | 25.75M | 14.59M | 8.92M | 4.55M | -15.58M | -5.45M | 7.75M | 11.25M | 18.17M | 14.53M | 9.90M | 12.16M | 16.25M | 5.08M | 1.53M | 8.50M | 5.39M | 16.01M | 9.87M | 5.71M | 2.64M | 3.19M | -1.80M | 1.23M | 128.98K | 6.30M | 4.60M |
| Income Before Tax Ratio | 7.20% | 3.86% | 2.90% | 2.04% | -5.48% | -2.02% | 4.79% | 6.43% | 9.13% | 8.29% | 6.87% | 7.48% | 11.33% | 5.06% | 1.84% | 7.29% | 4.40% | 9.86% | 7.56% | 5.10% | 2.84% | 3.39% | -2.64% | 1.47% | 0.14% | 8.11% | 7.09% |
| Income Tax Expense | 5.42M | 2.38M | 4.25M | -3.62M | -355.00K | -664.00K | 2.29M | 3.84M | 6.12M | 4.89M | 3.03M | 3.97M | 5.72M | 2.64M | 516.74K | 2.86M | 1.67M | 5.60M | 3.58M | 571.29K | 973.35K | 1.18M | 58.00K | 515.63K | 57.64K | 2.60M | 1.90M |
| Net Income | 20.32M | 12.20M | 4.67M | 8.17M | -15.22M | -4.78M | 5.46M | 7.41M | 12.05M | 9.63M | 6.87M | 8.19M | 10.53M | 2.43M | 1.02M | 5.64M | 3.73M | 10.41M | 6.29M | 5.13M | 1.67M | 2.01M | -1.86M | 715.35K | 71.34K | 3.70M | 2.70M |
| Net Income Ratio | 5.68% | 3.23% | 1.52% | 3.67% | -5.35% | -1.77% | 3.38% | 4.24% | 6.05% | 5.50% | 4.76% | 5.04% | 7.34% | 2.43% | 1.22% | 4.84% | 3.04% | 6.41% | 4.82% | 4.59% | 1.79% | 2.13% | -2.72% | 0.86% | 0.08% | 4.76% | 4.16% |
| EPS | 2.37 | 1.44 | 0.55 | 0.98 | -1.94 | -0.62 | 0.71 | 0.97 | 1.59 | 1.28 | 0.95 | 1.15 | 1.51 | 0.36 | 0.16 | 0.84 | 0.43 | 1.03 | 0.63 | 0.53 | 0.17 | 0.21 | -0.19 | 0.07 | 0.01 | 0.38 | 0.29 |
| EPS Diluted | 2.31 | 1.44 | 0.55 | 0.98 | -1.94 | -0.62 | 0.70 | 0.97 | 1.58 | 1.28 | 0.92 | 1.11 | 1.44 | 0.34 | 0.16 | 0.81 | 0.41 | 1.00 | 0.60 | 0.52 | 0.17 | 0.21 | -0.19 | 0.07 | 0.01 | 0.37 | 0.28 |
| Weighted Avg Shares Out | 8.55M | 8.36M | 8.06M | 7.94M | 7.83M | 7.71M | 7.69M | 7.62M | 7.58M | 7.51M | 7.22M | 7.10M | 6.95M | 6.85M | 6.77M | 6.74M | 8.69M | 10.08M | 9.91M | 9.78M | 9.78M | 9.78M | 9.78M | 10.22M | 9.78M | 9.71M | 9.31M |
| Weighted Avg Shares Out (Dil) | 8.77M | 8.37M | 8.06M | 7.94M | 7.83M | 7.75M | 7.75M | 7.66M | 7.62M | 7.55M | 7.44M | 7.38M | 7.30M | 7.07M | 6.82M | 6.99M | 9.00M | 10.39M | 10.41M | 9.82M | 9.78M | 9.78M | 9.78M | 10.22M | 9.82M | 9.98M | 9.64M |
COVID-19 Takes Shine Off Diamond City; Surat Now Next Hotspot
With over 5,000cases of coronavirus registered till now and a gradual increase in daily infections since the last two weeks, Surat city is emerging as the next COVID-19 hotspot in Gujarat after Ahmedabad.
Surat: Two new Covid facilities at SMC community hall, SGCCI premises
The SMC authorities along with Surat district administrative officials, visited the International Convention Cum Exhibition Centre at Sarsana on June 12 and started work to get clearances for a Covid-care facility on its premises.
Dog that bit Sibu Municipal Council employees has rabies
SIBU: The dog that had bitten two members of the Sibu Municipal Council (SMC) dog team on June 28 has tested positive for rabies.
Ready with action plan for Covid monitoring: Deb
Wards 18 and 28 cover a significant portion of slum areas.
SpaceX set for rocket recovery first after US military satellite launch
A SpaceX Falcon 9 is set to become the first commercial rocket to attempt to land after an operational launch for the US military, potentially paving the way for an even more significant milestone somewhere down the road. Featuring brand...
Shimla residents up in arms against inflated bills in COVID-19 crisis
Enraged over-inflated bills of electricity, water and property tax, Shimla Nagrik Sabha (SNS) on Monday staged a protest and accused the state government.
Over 17k workers in Surat diamond hub screened, Gujarat Covid tally 31,444
Of the total 19 deaths reported from the state, two were from Surat district and one from Surat city. Remaining 13 were reported from Ahmedabad city, while one each from Gandhinagar, Aravalli and Bharuch, taking the toll to 1,813.
Supreme Court: Ohio Pot Referendum Petitions Must Have Signatures
The Supreme Court refused last week to bend Ohio election rules to accommodate marijuana decriminalization advocates who failed ...
More markets in Siliguri shut
Family members said Biplab Saha had returned from Mumbai, where he used to work in a jewellery unit, on 22 June.
Source: https://incomestatements.info
Category: Stock Reports